Latest Contract research organizations Stories
LifeScienceIndustryResearch.com adds Latest Report on “China Contract Research Organization (CRO) Industry Report, 2013-2016” to its store.
SHANGHAI, May 23, 2014 /PRNewswire/ -- Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device
SHANGHAI, May 21, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a statement of Good Laboratory Practice (GLP) from the
Collaboration Will Ensure Local Monitoring and Centralized Clinical Research Technology for Sponsors of Multinational Clinical Trials Irvine, CA (PRWEB) May
Introducing eCongress on Optimizing Patient Participation in Clinical Trials, a new webinar series taking place in June.
SHANGHAI, May 13, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
SHANGHAI, May 12, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
BOSTON, May 9, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that its Chairman and CEO, Josef von Rickenbach,
SHANGHAI, May 8, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
SHANGHAI and TAIPEI, May 5, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX) and TaiMed Biologics today announced that the FDA has approved the first batch of the ibalizumab (TMB-355)
- A transitional zone between two communities containing the characteristic species of each.